2025 Exhibit 109: Prevalence of Utilization Management Tools, Medicare Part D Plans, 2025 Exhibit 110: Use of Prior Authorization and Step Therapy for Single-Source Brand-Name Drugs, by Therapeutic Class, 2023 Exhibit 111: Initial Plan Rejection Rates for Newly Prescribed Medicines, Commercial vs
Your prescriber will review your progress, weight, and any side effects before approving the next dose increase or decrease
Though Mounjaro is indicated for diabetes, only around half of new Mounjaro patients have a diabetes diagnosis, while a quarter have a weight-related diagnosis
When testosterone encounters 5-alpha reductase in hair follicle cells, it transforms into the more potent DHT molecule
Adverse events, clinical laboratory assessments, vital signs, and physical examinations were monitored at all study visits
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Fujita H., Morii T., Fujishima H., et al